These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 26543935)

  • 1. Myasthenia gravis is a rare but treatable disease.
    Mombaur B; Heckmann JM
    S Afr Med J; 2015 Aug; 105(8):619. PubMed ID: 26543935
    [No Abstract]   [Full Text] [Related]  

  • 2. Subunit specificity of the acetylcholine receptor antibodies in double seropositive myasthenia gravis.
    Zouvelou V; Michail M; Belimezi M; Zisimopoulou P
    Muscle Nerve; 2021 Apr; 63(4):E36-E37. PubMed ID: 33471417
    [No Abstract]   [Full Text] [Related]  

  • 3. [Myasthenia gravis (1). Experimental myasthenia gravis--a tool for the study of the pathogenesis, diagnosis and treatment of myasthenia gravis].
    Heilbronn E
    Lakartidningen; 1978 Oct; 75(41):3663-4, 3669. PubMed ID: 692231
    [No Abstract]   [Full Text] [Related]  

  • 4. [Antibodies to acetylcholine receptor. Diagnosis and therapeutic interest in myasthenia gravis (author's transl)].
    de Crousaz G
    Ann Chir; 1980 Mar; 34(3):188-92. PubMed ID: 7369693
    [No Abstract]   [Full Text] [Related]  

  • 5. An algorithm for acetylcholine receptor antibody testing in patients with suspected myasthenia gravis.
    Haven TR; Astill ME; Pasi BM; Carper JB; Wu LL; Tebo AE; Hill HR
    Clin Chem; 2010 Jun; 56(6):1028-9. PubMed ID: 20360127
    [No Abstract]   [Full Text] [Related]  

  • 6. [Clinical study of autoimmune diseases: recent trends--with special reference to progress in immunological tests and therapeutic methods. Organ-specific autoimmune diseases. 3) Myasthenia gravis].
    Arimori S
    Nihon Rinsho; 1988 Apr; 46(4):907-11. PubMed ID: 3404711
    [No Abstract]   [Full Text] [Related]  

  • 7. Immunosorbent treatment in myasthenia gravis.
    Passalacqua S; Splendiani G; Sturniolo A; Costanzi S; Barbera G; Bartoccioni E; Evoli A; Scoppetta C; Adorno D; Di Guilio S
    Prog Clin Biol Res; 1990; 337():285-8. PubMed ID: 2191321
    [No Abstract]   [Full Text] [Related]  

  • 8. [Myasthenia gravis (2). Antibodies against acetylcholinergic receptros in myasthenia gravis].
    Bergström K; Lefvert AK
    Lakartidningen; 1978 Oct; 75(41):3665-7. PubMed ID: 692232
    [No Abstract]   [Full Text] [Related]  

  • 9. Evidence of underdiagnosis of myasthenia gravis in older people.
    Vincent A; Clover L; Buckley C; Grimley Evans J; Rothwell PM;
    J Neurol Neurosurg Psychiatry; 2003 Aug; 74(8):1105-8. PubMed ID: 12876244
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Intravenous gamma-globulin in myasthenia gravis: interaction with anti-acetylcholine receptor autoantibodies.
    Liblau R; Gajdos P; Bustarret FA; el Habib R; Bach JF; Morel E
    J Clin Immunol; 1991 May; 11(3):128-31. PubMed ID: 1716263
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Acetylcholine receptor antibody as a diagnostic test for myasthenia gravis: results in 153 validated cases and 2967 diagnostic assays.
    Vincent A; Newsom-Davis J
    J Neurol Neurosurg Psychiatry; 1985 Dec; 48(12):1246-52. PubMed ID: 4087000
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antibody to acetylcholine receptor in myasthenia gravis: prevalence, clinical correlates, and diagnostic value. 1975.
    Lindstrom JM; Seybold ME; Lennon VA; Whittingham S; Duane DD
    Neurology; 1998 Oct; 51(4):933 and 6 pages following. PubMed ID: 9781505
    [No Abstract]   [Full Text] [Related]  

  • 13. Seropositive myasthenia gravis: a nationwide epidemiologic study.
    Heldal AT; Owe JF; Gilhus NE; Romi F
    Neurology; 2009 Jul; 73(2):150-1. PubMed ID: 19597135
    [No Abstract]   [Full Text] [Related]  

  • 14. High-dose intravenous immunoglobulin in transient neonatal myasthenia gravis.
    Bassan H; Muhlbaur B; Tomer A; Spirer Z
    Pediatr Neurol; 1998 Feb; 18(2):181-3. PubMed ID: 9535308
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Anti-MuSK positivity on plasmapheresis liquid in a double seronegative myasthenia gravis patient.
    Renard D; Candon S; Jacob M; Trusson R; Reboul P
    Acta Neurol Belg; 2018 Mar; 118(1):119-120. PubMed ID: 28608313
    [No Abstract]   [Full Text] [Related]  

  • 16. Anti-MuSK antibody myasthenia gravis: clinical findings and response to treatment in two large cohorts.
    Guptill JT; Sanders DB; Evoli A
    Muscle Nerve; 2011 Jul; 44(1):36-40. PubMed ID: 21674519
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Muscle-Specific Receptor Tyrosine Kinase (MuSK) Myasthenia Gravis.
    Hurst RL; Gooch CL
    Curr Neurol Neurosci Rep; 2016 Jul; 16(7):61. PubMed ID: 27170368
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Transient neonatal myasthenia gravis in a baby born to a mother with new-onset anti-MuSK-mediated myasthenia gravis.
    O'carroll P; Bertorini TE; Jacob G; Mitchell CW; Graff J
    J Clin Neuromuscul Dis; 2009 Dec; 11(2):69-71. PubMed ID: 19955986
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Overcoming challenges in the diagnosis and treatment of myasthenia gravis.
    Evoli A; Iorio R; Bartoccioni E
    Expert Rev Clin Immunol; 2016; 12(2):157-68. PubMed ID: 26675896
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Anti-MuSK myasthenia gravis presenting with purely ocular findings.
    Caress JB; Hunt CH; Batish SD
    Arch Neurol; 2005 Jun; 62(6):1002-3. PubMed ID: 15956173
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.